Sonoma Biotherapeutics is a private drug discovery company. It has raised $265 million across 1 recorded round; the latest was a $265 million Series B in Aug 2021.
PMV mark · valuation
—
Oct 2026
Priced at
—
Total raised
$265.0M
Last round
Early Stage VC (Series B)
Aug 2021
Investors — not yet on record
No investors in Sonoma Biotherapeutics are on record yet. Backers surface from round announcements, filings, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Sonoma Biotherapeutics with a free account
·Watch Sonoma Biotherapeutics: the Monday email on marks, rounds and moves
